BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16680754)

  • 1. Another case of myelodysplasia with monosomy 7 following fludarabine-based chemotherapy.
    Murphy PT; Mitra S; O'Donghaile D
    Am J Hematol; 2006 Jun; 81(6):473. PubMed ID: 16680754
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
    Trojan A; Meier R; Licht A; Taverna C
    Ann Hematol; 2002 Sep; 81(9):535-7. PubMed ID: 12373357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy shortly after the diagnosis of follicular lymphoma in a patient treated with fludarabine.
    Rodríguez L; Ribera JM; Batlle M; Xicoy B; Mate JL; Millá F; Feliu E
    Haematologica; 2002 Jul; 87(7):ECR26. PubMed ID: 12091141
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
    Au WY; Chan LC; Liang R; Kwong YL
    Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenström's macroglobulinemia after sequential treatment with chlorambucil and fludarabine.
    Shin SJ; Chun SH; Kim KO; Kim MK; Lee KH; Hyun MS; Cho HS
    Jpn J Clin Oncol; 2005 Oct; 35(10):622-5. PubMed ID: 16172172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary myelodysplastic syndrome with monosomy 7].
    Inokuchi K; Tajika K; Ito T; Ogata K; Yamada T; Tanabe Y; Ohki I; Dan K; Kuriya S; Nomura T
    Rinsho Ketsueki; 1988 May; 29(5):718-22. PubMed ID: 3216498
    [No Abstract]   [Full Text] [Related]  

  • 8. Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine.
    Van Den Neste E; Louviaux I; Michaux JL; Delannoy A; Michaux L; Hagemeijer A; Scheiff JM; Bosly A; Straetmans N; Ferrant A
    Br J Haematol; 1999 Apr; 105(1):268-70. PubMed ID: 10233391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment-related myelodysplasia following fludarabine combination chemotherapy.
    Tam CS; Seymour JF; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Westerman D
    Haematologica; 2006 Nov; 91(11):1546-50. PubMed ID: 17082012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
    McLaughlin P; Estey E; Glassman A; Romaguera J; Samaniego F; Ayala A; Hayes K; Maddox AM; Preti HA; Hagemeister FB
    Blood; 2005 Jun; 105(12):4573-5. PubMed ID: 15741224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.
    Coso D; Costello R; Cohen-Valensi R; Sainty D; Nezri M; Gastaut JA; Bouabdallah R
    Ann Oncol; 1999 Mar; 10(3):362-3. PubMed ID: 10355587
    [No Abstract]   [Full Text] [Related]  

  • 12. Transformation of severe aplastic anemia into myelodysplastic syndrome with monosomy 7: monoclonal origin detected by HUMARA gene analysis during the aplastic anemia phase.
    Sashida G; Tauchi T; Katagiri T; Kuriya S; Ohyashiki K
    Haematologica; 2000 Jun; 85(6):665-6. PubMed ID: 10870128
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA).
    Kroft SH; Tallman MS; Shaw JM; Thangavelu M; Peterson LC
    Leukemia; 1997 Jan; 11(1):170. PubMed ID: 9001435
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal monosomy 7 and 5q--in a child with myelodysplastic syndrome.
    Chantrain C; Vermylen C; Michaux L; Brichard B; Cornu G
    Pediatr Hematol Oncol; 2000 Sep; 17(6):505-9. PubMed ID: 10989472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplasia and myeloproliferative disorders in childhood: an update.
    Emanuel PD
    Br J Haematol; 1999 Jun; 105(4):852-63. PubMed ID: 10554793
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial childhood monosomy 7 and associated myelodysplasia.
    Gaitonde S; Boumendjel R; Angeles R; Rondelli D
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e236-7. PubMed ID: 20661156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline-fludarabine-containing regimens with or without rituximab in the treatment of patients with advanced follicular lymphoma.
    Luminari S; Marcheselli L; Sacchi S; Pozzi S; Bari A; Ilariucci F; Stelitano C; Angrilli F; Lazzaro A; Baldini L
    Cancer; 2009 May; 115(9):1906-13. PubMed ID: 19248044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of myelodysplastic syndrome in a patient with chronic myelogenous leukemia treated with imatinib.
    Mallik N; Chopra A; Jha A; Gogia A; Kumar R
    Leuk Lymphoma; 2015 Apr; 56(4):1143-4. PubMed ID: 25093381
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records.
    Bernardeschi P; Fiorentini G; Dentico P; Rossi S; Turrisi G; Del Conte A; Giannessi PG; Giustarini G; Montenora I
    Leukemia; 2008 Sep; 22(9):1781-2. PubMed ID: 18337763
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment-related acute myeloid leukemia with 11q23 translocation following treatment with fludarabine, cyclophosphamide and rituximab.
    Martin-Salces M; Canales MA; de Paz R; Hernandez-Navarro F
    Leuk Res; 2008 Jan; 32(1):199-200. PubMed ID: 17870157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.